REQUEST A DEMO
Total
USD $0.00
Search more companies

Gsk Pharmaceutical Trading SA (Romania)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Gsk Pharmaceutical Trading SA Profile Updated: September 13, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Europharm SA is a manufacturer and distributor of pharmaceutical products in Romania. The company was founded in 1992 by Mihai Miron, professional pharmacist, initially as a network of several pharmacies, later extended by production and distribution. In 1998, GlaxoSmithKline has acquired 65% in the company. In 2003, the last full Europharm owned GSK, which has full control of production and distribution activities.

Headquarters
Strada Costache Negri Nr. 1-5
Bucharest; Bucharest; Postal Code: 050552

Contact Details: Purchase the Gsk Pharmaceutical Trading SA report to view the information.

Website: http://www.gsk.com

Basic Information
Outstanding Shares:
Purchase the Gsk Pharmaceutical Trading SA report to view the information.
Registered Capital:
Purchase the Gsk Pharmaceutical Trading SA report to view the information.
Financial Auditors:
Purchase the Gsk Pharmaceutical Trading SA report to view the information.
Ratings:
Purchase the Gsk Pharmaceutical Trading SA report to view the information.
Incorporation Date:
December 30, 1994
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
65.0242%
Purchase this report to view the information.
34.7826%
Purchase this report to view the information.
0.0966%
Purchase this report to view the information.
0.0966%
Subsidiaries
Registrul Independent Monitor SA
3.33%
Company Performance
Financial values in the chart are available after Gsk Pharmaceutical Trading SA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
55.37%
Net Profit (Loss) for the Period
-8.3%
Total assets
1.34%
Total equity
1.39%
Return on Equity (ROE)
-0.14%
Quick Ratio
67.46%
Cash Ratio
64.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?